Zacks Investment Research
24 Jul 2026, 16:51 UTC · 59m ago
HCA Q2 Earnings Beat on Strong Admissions, 2026 Outlook Revised
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Zacks Investment Research
24 Jul 2026, 16:51 UTC · 59m ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
5 claims · each scored for market impact
HCA Healthcare reported Q2 2026 adjusted EPS of $7.59, beating the Zacks Consensus Estimate of $7.57. — An earnings beat generally provides a short-term positive catalyst for the stock price.
+0.30HCA's Q2 revenues rose 8.7% year-over-year to $20.2 billion, meeting consensus estimates. — Steady revenue growth confirms fundamental business scaling, though lack of a beat limits the upside.
+0.20Same-facility equivalent admissions grew 2.7% and same-facility admissions increased 2.5%, both surpassing growth estimates. — Stronger-than-expected organic volume growth indicates healthy demand for the company's core services.
+0.20Continue reading
6 related stories
Top 3 movers · tap to explore
Operating expenses (salaries, benefits, and supplies) increased 9.8% year-over-year to $16.2 billion, exceeding the $15.4 billion estimate. — Higher-than-expected operating costs can compress margins and signal inflationary pressure on labor and supplies.
Same-facility inpatient surgeries fell 2.3% and outpatient surgeries dipped 3.4% year-over-year. — Declines in high-margin surgical volumes are a negative trend for long-term profitability.
-0.10Which stocks this story touches
The company reported a beat on adjusted EPS and revenue growth, though elevated operating expenses provided some offset.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
2h ago